|
1
|
Yonkers KA, O’Brien PM and Eriksson E:
Premenstrual syndrome. Lancet. 371:1200–1210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shah NR, Jones JB, Aperi J, Shemtov R,
Karne A and Borenstein J: Selective serotonin reuptake inhibitors
for premenstrual syndrome and premenstrual dysphoric disorder: a
meta-analysis. Obstet Gynecol. 111:1175–1182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown J, O’Brien PM, Marjoribanks J and
Wyatt K: Selective serotonin reuptake inhibitors for premenstrual
syndrome. Cochrane Database Syst Rev. 15:CD0013962009.
|
|
4
|
Biggs WS and Demuth RH: Premenstrual
syndrome and premenstrual dysphoric disorder. Am Fam Physician.
84:918–924. 2011.PubMed/NCBI
|
|
5
|
Nijenhuis CM, Horst PG, Berg LT and
Wilffert B: Disturbed development of the enteric nervous system
after in utero exposure of selective serotonin re-uptake inhibitors
and tricyclic antidepressants. Part 1: Literature review. Br J Clin
Pharmacol. 73:16–26. 2012. View Article : Google Scholar
|
|
6
|
Sansone RA and Sansone LA: SSRIs: bad to
the bone? Innov Clin Neurosci. 9:42–47. 2012.PubMed/NCBI
|
|
7
|
Tatara A, Shimizu S, Shin N, Sato M,
Sugiuchi T, Imaki J and Ohno Y: Modulation of antipsychotic-induced
extra pyramidal side effects by medications for mood disorders.
Prog Neuropsychopharmacol Biol Psychiatry. 38:252–259. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tan Q and Zhang HY: Effect of shuyu
capsule on location and expression of 5-hydroxy tryptamine3B
receptor in hippocampus and hypothalamus regions in rats with
depression emotion. Chinese Journal of Experimental Traditional
Medical Formulae. 17:137–139. 2011.
|
|
9
|
Jiang YF, Gao J, Wei S, Xue L and Ge QF:
Effect of shuyu capsule contained serum on the expression of
γ-aminobutyric acid B2 receptor in primary cultured rat hippocampal
neurons. Chinese Journal of Experimental Traditional Medical
Fomulae. 18:165–169. 2012.
|
|
10
|
Allen LM and Lam AC: Premenstrual syndrome
and dysmenorrhea in adolescents. Adolesc Med State Art Rev.
23:139–163. 2012.PubMed/NCBI
|
|
11
|
Pereira-Vega A, Sánchez Ramos JL, Vázquez
Oliva R, et al: Premenstrual asthma and female sex hormones. J
Investig Allergol Clin Immunol. 22:437–439. 2012.PubMed/NCBI
|
|
12
|
Rapkin AJ and Akopians AL: Pathophysiology
of premenstrual syndrome and premenstrual dysphoric disorder.
Menopause Int. 18:52–59. 2012.PubMed/NCBI
|
|
13
|
Wilson CL, Maidment NT, Shomer MH, Behnke
EJ, Ackerson L, Fried I and Engel J Jr: Comparison of seizure
related amino acid release in human epileptic hippocampus versus a
chronic, kainate rat model of hippocampal epilepsy. Epilepsy Res.
26:245–254. 1996. View Article : Google Scholar
|
|
14
|
Aguilera A, Selgas R, Codoceo R and Bajo
A: Uremic anorexia: a consequence of persistently high brain
serotonin levels? The tryptophan/serotonin disorder hypothesis.
Perit Dial Int. 20:810–816. 2000.PubMed/NCBI
|
|
15
|
Mitchell ND and Baker GB: An update on the
role of glutamate in the pathophysiology of depression. Acta
Psychiatr Scand. 122:192–210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mueller PJ and Mischel NA: Selective
enhancement of glutamate-mediated pressor responses after GABA(A)
receptor blockade in the RVLM of sedentary versus spontaneous wheel
running rats. Front Physiol. 3:4472012. View Article : Google Scholar
|
|
17
|
Crabtree JW, Lodge D, Bashir ZI and Isaac
JT: GABAA, NMDA and mGlu2 receptors tonically regulate inhibition
and excitation in the thalamic reticular nucleus. Eur J Neurosci.
37:850–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Batra NA, Seres-Mailo J, Hanstock C, et
al: Proton magnetic resonance spectroscopy measurement of brain
glutamate levels in premenstrual dysphoric disorder. Biol
Psychiatry. 63:1178–1184. 2008. View Article : Google Scholar
|
|
19
|
Krystal JH, Sanacora G, Blumberg H, et al:
Glutamate and GABA systems as targets for novel antidepressant and
mood-stabilizing treatments. Mol Psychiatry. 7(Suppl 1): S71–80.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kendell SF, Krystal JH and Sanacora G:
GABA and glutamate systems as therapeutic targets in depression and
mood disorders. Expert Opin Ther Targets. 9:153–168. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zorumski CF, Paul SM, Izumi Y, Covey DF
and Mennerick S: Neurosteroids, stress and depression: potential
therapeutic opportunities. Neurosci Biobehav Rev. 37:109–122. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Konradi C and Heckers S: Molecular aspects
of glutamate dysregulation: implications for schizophrenia and its
treatment. Pharmacol Ther. 97:153–179. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Epperson CN, Haga K, Mason GF, et al:
Cortical gamma-aminobutyric acid levels across the menstrual cycle
in healthy women and those with premenstrual dysphoric disorder: a
proton magnetic resonance spectroscopy study. Arch Gen Psychiatry.
59:851–858. 2002. View Article : Google Scholar
|
|
24
|
Duman RS, Malberg J, Nakagawa S and D’Sa
C: Neuronal plasticity and survival in mood disorders. Biol
Psychiatry. 48:732–739. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bäckström T, Haage D, Löfgren M, et al:
Paradoxical effects of GABA-A modulators may explain sex steroid
induced negative mood symptoms in some persons. Neuroscience.
191:46–54. 2011.PubMed/NCBI
|
|
26
|
Zhang HY, Wei S, Sun P, Xue L and Qiao MQ:
Empirical study of changes of pre-menstrual syndrome model rats
with liver-qi invasion and liver-qi depression in peripheral blood,
sexual hormones, different encephalic regions and accommodate
hormones. World Science and Technology. 12:51–56. 2010. View Article : Google Scholar
|
|
27
|
Shigemi K, Tsuneyoshi Y, Yamada S, Kabuki
Y, Hayamizu K, Denbow DM and Furuse M: Oral administration of
L-serine reduces the locomotor activity of socially isolated rats.
Neurosci Lett. 468:75–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rygula R, Abumaria N, Havemann-Reinecke U,
et al: Pharmacological validation of a chronic social stress model
of depression in rats: effects of reboxetine, haloperidol and
diazepam. Behav Pharmacol. 19:183–196. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pandey DK, Mahesh R, Kumar AA, Rao VS,
Arjun M and Rajkumar R: A novel 5-HT(2A) receptor antagonist
exhibits antidepressant-like effects in a battery of rodent
behavioural assays: approaching early-onset antidepressants.
Pharmacol Biochem Behav. 94:363–373. 2010. View Article : Google Scholar
|
|
30
|
Paxinos G and Watson C: The Rat Brain in
Stereotaxic Coordinates-The New Coronal Set. 5th edition. Elsevier
Academic Press; San Diego, CA: pp. 272005
|
|
31
|
Ho HP, Olsson M, Westberg L, Melke J and
Eriksson E: The serotonin reuptake inhibitor fluoxetine reduces sex
steroid-related aggression in female rats: an animal model of
premenstrual irritability? Neuropsychopharmacology. 24:502–510.
2001. View Article : Google Scholar
|
|
32
|
Smith SS, Ruderman Y, Hua Gong Q and
Gulinello M: Effects of a low dose of ethanol in an animal model of
premenstrual anxiety. Alcohol. 33:41–49. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Võikar V, Rauvala H and Ikonen E:
Cognitive deficit and development of motor impairment in a mouse
model of Niemann-Pick type C disease. Behav Brain Res. 132:1–10.
2002.PubMed/NCBI
|
|
34
|
Rupprecht R: Neuroactive steroids:
mechanisms of action and neuropsychopharmacological properties.
Psychoneuroendocrinology. 28:139–168. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cunningham J, Yonkers KA, O’Brien S and
Eriksson E: Update on research and treatment of premenstrual
dysphoric disorder. Harv Rev Psychiatry. 17:120–137. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qiao M, Zhao Q, Zhang H, Wang H, Xue L and
Wei S: Isolating with physical restraint low status female monkeys
during luteal phase might make an appropriate premenstrual
depression syndrome model. J Affect Disord. 102:81–91. 2007.
View Article : Google Scholar
|
|
37
|
Qiao M, Zhang H, Yu Y, Ci Y, Xu X, Ye Q
and Chen Y: Dynamic changes in serum estradiol and progesterone
levels in patients of premenstrual syndrome with adverse flow of
liver-qi. J Tradit Chin Med. 28:106–109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qiao M, Zhang H, Liu H, et al: Prevalence
of premenstrual syndrome and premenstrual dysphoric disorder in a
population-based sample in China. Eur J Obstet Gynecol Reprod Biol.
162:83–86. 2012. View Article : Google Scholar : PubMed/NCBI
|
